EX-4.21 AGREEMENT - SURRENDER OF SHARES/STOCK OPTIONS/WARRANTS - INVESTORS
September 13, 2001
ConSyGen, Inc.
▇▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Attn: ▇▇▇▇ ▇▇▇▇▇▇▇▇, CFO
Re: Deferral of Share Issuance
Ladies and Gentlemen:
As of September 13, 2001, the undersigned holds an aggregate of ____________
shares of common stock (the "Shares") of ConSyGen, Inc. (the "Company"), which
the undersigned has agreed to surrender to the Company. The undersigned
understands that the Company does not currently have sufficient authorized but
unissued shares of common stock to execute its business and financial plans. In
consideration of the foregoing and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the undersigned does
hereby waive his right to receive the shares until such time as the Company
increases to at least 125,000,000 the number of the Company's authorized shares
of common stock. Following such increase, the Company shall have the option to
either (i) issue the undersigned ____________ shares of its common stock, or
(ii) pay the undersigned an aggregate of $_________, in lieu of issuing such
shares to the undersigned. The Company shall use its best efforts to cause the
number of its authorized shares of common stock to be increased to at least
125,000,000 within ninety (90) days of the date hereof.
Sincerely,
[Name]
AGREED AND ACCEPTED:
ConSyGen, Inc.
By:
Name: ▇▇▇▇▇▇ ▇▇▇▇▇▇
Title: Chief Executive Officer,
duly authorized
By:
Name: ▇▇▇▇ ▇▇▇▇▇▇▇▇
Title: Chief Financial Officer,
duly authorized
September 13, 2001
ConSyGen, Inc.
▇▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Attn: ▇▇▇▇ ▇▇▇▇▇▇▇▇, CFO
Re: Deferral of Share Issuance
Ladies and Gentlemen:
As of September 13, 2001, the undersigned is entitled to an option for an
aggregate of _________ shares of common stock (the "Options") of ConSyGen, Inc.
(the "Company"). The undersigned understands that the Company does not currently
have sufficient authorized but unissued shares of common stock to execute its
business and financial plans. In consideration of the foregoing and other good
and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the undersigned does hereby waive his right to exercise the
options until such time as the Company increases to at least 125,000,000 the
number of the Company's authorized shares of common stock. Following such
increase, the Company shall issue to the undersigned an option for _________
shares of its common stock at an exercise price of $0.50 per share. The Company
shall use its best efforts to cause the number of its authorized shares of
common stock to be increased to at least 125,000,000 within ninety (90) days of
the date hereof.
Sincerely,
[Name]
AGREED AND ACCEPTED:
ConSyGen, Inc.
By:
Name: ▇▇▇▇▇▇ ▇▇▇▇▇▇
Title: Chief Executive Officer,
duly authorized
By:
Name: ▇▇▇▇ ▇▇▇▇▇▇▇▇
Title: Chief Financial Officer,
duly authorized
September 13, 2001
ConSyGen, Inc.
▇▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Attn: ▇▇▇▇ ▇▇▇▇▇▇▇▇, CFO
Re: Deferral of Share Issuance
Ladies and Gentlemen:
As of September 13, 2001, the undersigned is entitled to an option for an
aggregate of ___________ warrants of common stock (the "Warrants") of ConSyGen,
Inc. (the "Company"). The undersigned understands that the Company does not
currently have sufficient authorized but unissued shares of common stock to
execute its business and financial plans. In consideration of the foregoing and
other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the undersigned does hereby waive his right to exercise the
warrants until such time as the Company increases to at least 125,000,000 the
number of the Company's authorized shares of common stock. Following such
increase, the Company shall issue to the undersigned a warrant for __________
shares of its common stock at an exercise price of $0.25 per share. The Company
shall use its best efforts to cause the number of its authorized shares of
common stock to be increased to at least 125,000,000 within ninety (90) days of
the date hereof.
Sincerely,
[Name]
AGREED AND ACCEPTED:
ConSyGen, Inc.
By:
Name: ▇▇▇▇▇▇ ▇▇▇▇▇▇
Title: Chief Executive Officer,
duly authorized
By:
Name: ▇▇▇▇ ▇▇▇▇▇▇▇▇
Title: Chief Financial Officer,
duly authorized
